Tectonic Therapeutics TECX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$83.49M-42.3% | -$74.15M-27.9% | -$67.3M-25.8% | -$65.98M-44.0% | -$58.67M-77.0% | ||
| $1.32M-19.0% | $1.38M-16.4% | $1.55M+2.6% | $1.63M+12.0% | $1.63M+15.5% | ||
| $11.6M+120% | $10.5M+201% | $8.63M+223% | $7.46M+477% | $5.27M— | ||
| -$65.41M-4.0% | -$60.08M-1.7% | -$62.44M-15.8% | -$64.23M-50.1% | -$62.89M-112% | ||
| —— | —— | —— | —— | $179K-34.9% | ||
| -$130K+27.4% | -$138K+11.5% | -$141K+30.5% | -$128K-125% | -$179K+34.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$65.61M-4.0% | -$60.29M-1.8% | -$62.65M-15.8% | -$64.41M-50.3% | -$63.07M-111% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tectonic Therapeutics generate?
- Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
- What is Tectonic Therapeutics's free cash flow?
- After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
- Where does Tectonic Therapeutics's cash flow data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.